Plant-Derived Human Vaccines; An Overview

Human brucellosis: An overview

An overview on Leishmania vaccines: A narrative review article

Leishmaniasis is one of the major health problems and categorized as a class I disease (emerging and uncontrolled) by World Health Organization (WHO), causing highly significant morbidity and mortality. Indeed, more than 350 million individuals are at risk of Leishmania infection, and about 1.6 million new cases occur causing more than 50 thousands death annually. Because of the severe...

DNA Vaccines – An Overview

Administration of genes via DNA or RNA may be considered the next-generation of scientific development following the use of recombinant proteins for prophylactic vaccines or for therapy. The use of DNA vaccines for the generation of immune responses arose from efforts to find immunogens that would be able to overcome some of the limitations of other modalities of vaccination. With the discovery...

STD vaccines--an overview.

OBJECTIVES To describe the role and current status of vaccine research against sexually transmitted diseases (STDs). METHODS The available literature was reviewed with particular emphasis on bacterial STDs. RESULTS Strategic approaches to possible implementation of STD vaccine programmes were analysed. The status of vaccines against bacterial STDs (syphilis, chancroid, gonorrhoea, and chlam...

Rotavirus vaccines: an overview.

Rotavirus vaccine development has focused on the delivery of live attenuated rotavirus strains by the oral route. The initial "Jennerian" approach involving bovine (RIT4237, WC3) or rhesus (RRV) rotavirus vaccine candidates showed that these vaccines were safe, well tolerated, and immunogenic but induced highly variable rates of protection against rotavirus diarrhea. The goal of a rotavirus vac...